Cell therapy weekly: FDA issues strong warning, diabetes gene therapy shows promise in mice, the Cell and Gene Therapy Catapult unveils new project and Takeda eyes an acquisition
In this new weekly column, Editor Freya Leask rounds up her news highlights from the last 7 days.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.